Company Information

Home | Market | Company Info | Overview

GROUP NEWS

Aarti Drugs Ltd.

BSE

Jun 16, 11:33
455.50
-8.50 ( -1.83%)
Volume 7678
Prev. Close 464.00
Open Price 463.50
Today's Low / High
454.05
     
466.75
Bid Price(Qty.) 455.00 (236)
Offer Pr.(Qty.) 455.95 (42)
52 Wk Low / High
312.50
     
634.90

NSE

Jun 16, 11:19
457.10
-6.65 ( -1.43%)
Volume 68395
Prev. Close 463.75
Open Price 460.05
Today's Low / High
454.35
     
468.05
Bid Price(Qty.) 457.05 (27)
Offer Pr.(Qty.) 457.45 (15)
52 Wk Low / High
312.00
     
635.00
You can view the latest news of the Business Group.
ISIN No INE767A01016 Market Cap. ( ₹ in Cr. ) 4171.95 P/BV 3.27 Book Value ( ₹ ) 139.96
BSE Code 524348 52 Week High/Low ( ₹ ) 635/312 FV/ML 10/1 P/E(X) 24.81
NSE Code AARTIDRUGSEQ Book Closure 04/02/2025 EPS ( ₹ ) 18.42 Div Yield (%) 0.22
Date and TimeHeadlines
14/06/2025 18:35 Aarti Drugs Ltd - Copy of Newspaper Publication
22/05/2025 18:39 Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
22/05/2025 18:36 Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - ...
13/05/2025 Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
08/05/2025 23:51 Aarti Drugs Ltd - Updates
07/05/2025 18:51 Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - ...
07/05/2025 18:51 Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
07/05/2025 00:45 Aarti Drugs Ltd - Disclosure Under Regulation 30 - Ad-Interim Order By The Court
07/05/2025 00:45 Aarti Drugs Ltd - Action(s) taken or orders passed
06/05/2025 20:54 Aarti Drugs Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance...
06/05/2025 19:00 Aarti Drugs Ltd - Investor Presentation
06/05/2025 19:00 Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation
06/05/2025 18:56 Aarti Drugs Ltd - Press Release
06/05/2025 18:56 Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Rele...
06/05/2025 16:30 Aarti Drugs Ltd Q4 net profit jumps 70.12% at Rs 61.48 cr
06/05/2025 16:29 Aarti Drugs Ltd - Outcome of Board Meeting
06/05/2025 16:27 Aarti Drugs Ltd - Board Meeting Outcome for Financial Results For The Quarter And Ye...
06/05/2025 16:24 Aarti Drugs Ltd - Outcome Of The Board Meeting And Financial Results For The Quarter...
06/05/2025 16:24 Aarti Drugs Ltd - Outcome of Board Meeting
29/04/2025 22:45 Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
29/04/2025 22:43 Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - ...
29/04/2025 19:19 Aarti Drugs Ltd - Board Meeting Intimation for Audited Financial Results For The Qua...
29/04/2025 19:10 Aarti Drugs Ltd - Board Meeting Intimation
18/04/2025 20:30 Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended M...
08/04/2025 11:47 Aarti Drugs Ltd - Certificate under SEBI (Depositories and Participants) Regulations...
08/04/2025 11:43 Aarti Drugs Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations...
02/04/2025 15:54 Aarti Drugs Ltd - Action(s) taken or orders passed
02/04/2025 15:53 Aarti Drugs Ltd - Disclosure Under Regulation 30 Of SEBI Listing Regulations
29/03/2025 14:57 Aarti Drugs Ltd - Trading Window-XBRL
29/03/2025 14:56 Aarti Drugs Ltd - Trading Window

TRADEWELL SECURITIES LIMITED
CORPORATE MEMBER OF BOMBAY STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID : 3187  |  NATIONAL STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID: 12835>  |  MULTI COMMODITY EXCHANGE OF INDIA LTD  |  MEMBER ID: 56265
SEGMENTS: BSE CASH  |  BSE STAR MF  |  NSE CASH  |  NSE FO  |  NSE CD  |  NSE MF
SEBI REGN NO. INZ000171936
AMFI ARN CODE: 111875
CDSL DP ID NO. : 12052700 DP SEBI REG.NO.IN-DP-CDSL-432-2007
NSE | BSE | RBI | SEBI | CDSL | MCX | AMFI | SCORES

ATTENTION INVESTORS "Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)


Copyright © 2015 Tradewell Securities Limited. All rights reserved.

Designed, developed and content provided by dion

SMS Registration

Submit Clear

Mobile Trading

Segment

Submit Clear

logo

Submit Clear

Investors Grievances

igtsl@tradewellmail.com

Invest By QFI

QFI's Can now invest in Indian Capital Markets Through Tradewell Securities ltd -
For details Contact
Mr K.Brahmaiah - 9246399440/040-23541258.

CLIENT LOGIN

NOTES:

FRANCHISEE LOGIN

NOTES:

INTERNET TRADING

NOTES: